Loading...
Pilot Study of Pentoxifylline in Hepatopulmonary Syndrome
Hepatopulmonary syndrome (HPS) results when chronic liver disease or portal hypertension causes intrapulmonary microvascular dilatation with hypoxemia. In experimental HPS, tumor necrosis factor alpha (TNF-α) overproduction contributes to vasodilatation, which is improved by pentoxifylline, a TNF-α...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
2008
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2834782/ https://ncbi.nlm.nih.gov/pubmed/18668653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lt.21482 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|